Inhibitor | Substrate Uptake Relative to Control | |
---|---|---|
[3H]Ipratropium | [3H]Tiotropium | |
% | ||
None (control) | 100 ± 7.80 | 100 ± 2.29 |
Ipratropium | 14.9 ± 1.31* | 25.6 ± 1.01* |
MPP+ | 23.5 ± 1.97* | 39.8 ± 1.77* |
Cimetidine | 36.7 ± 1.28* | 54.5 ± 2.17* |
Quinidine | 32.0 ± 2.03* | 34.9 ± 1.40* |
TEA+ | 56.9 ± 3.09* | 67.3 ± 2.51* |
Imipramine | 22.7 ± 3.53* | 36.7 ± 1.92* |
PAH | 88.7 ± 6.19 | 97.4 ± 4.30 |
Estrone 3-Sulfate | 83.2 ± 5.67 | 104 ± 6.52 |
PAH, p-aminohippuric acid.
↵* Statistically significant difference versus control (p < 0.05) by Student's t test.